Publications by authors named "Lourdes Mollard"

Objective: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality globally. In our region, there is a scarcity of studies addressing its epidemiology and treatment. The aim was to characterize a cohort of HCC patients in a high-complexity public center in Argentina over a span of 10 years.

View Article and Find Full Text PDF
Article Synopsis
  • Hepatocellular carcinoma (HCC) is the most prevalent type of primary liver cancer and is a leading cause of cancer deaths globally, with treatment options varying based on whether the patient has cirrhosis.
  • A retrospective study at Hospital El Cruce over seven years analyzed 44 patients who underwent hepatic resection, evaluating their recovery outcomes, recurrence rates, and overall survival.
  • Findings indicated that 59% of patients experienced disease recurrence, with factors like tumor size and AFP levels influencing this; surprisingly, cirrhotic patients showed better survival rates than non-cirrhotic ones, highlighting the need for ongoing monitoring for recurrence.
View Article and Find Full Text PDF

We present the case of forty-four-year-old woman with autosomal dominant Polycystic liver disease (PLD) without kidney disease diagnosed for 18 years ago. She experienced progressive abdominal distension and malnutrition over the previous twelve months. The patient had no other comorbidities.

View Article and Find Full Text PDF

Introduction: Bile duct injuries (BDI) following laparoscopic cholecystectomy occurs in approximately 0.6% of the cases, often being more severe and complex. Roux-en-Y hepaticojejunostomy (RYHJ) is considered the optimal therapeutic option, with success rates ranging from 75% to 98%.

View Article and Find Full Text PDF
Article Synopsis
  • Cholecystocolonic fistula (CCF) is the second most frequent type of cholecystoenteric fistula and is mostly linked to gallstone disease.
  • Symptoms of CCF are typically mild or vague, making it hard to diagnose before surgery.
  • While only 1.7% of CCF cases are due to gallbladder cancer, considering this possibility is crucial for effective treatment planning.
View Article and Find Full Text PDF